Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Oncotarget|January 31, 2012
Histone modification defects in developmental disorders and cancerNicholas C P Cross
Blood|April 29, 2008
Hitchhikers' guide to the leukemia genomeNicholas C P Cross
Best Practice & Research. Clinical Haematology|December 5, 2009
Standardisation of molecular monitoring for chronic myeloid leukaemiaNicholas C P Cross
Hematology. American Society of Hematology. Education Program|December 14, 2011
Genetic and epigenetic complexity in myeloproliferative neoplasmsNicholas C P Cross
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Update on CML-Like DisordersNicholas C P Cross
Acta Haematologica|June 21, 2008
Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disordersNicholas C P Cross, Andreas Reiter
International Journal of Hematology|September 13, 2014
Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiableKaterina Zoi, Nicholas C P Cross
Hematology/Oncology Clinics of North America|September 27, 2012
Acquired uniparental disomy in myeloproliferative neoplasmsJoannah Score, Nicholas C P Cross
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Genomics of Myeloproliferative NeoplasmsKaterina Zoi, Nicholas C P Cross
Clinical Science (London, England : 1979)|September 12, 2006
Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinasesAndrew Chase, Nicholas C P Cross
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Oncotarget|January 31, 2012
Histone modification defects in developmental disorders and cancerNicholas C P Cross
Blood|April 29, 2008
Hitchhikers' guide to the leukemia genomeNicholas C P Cross
Best Practice & Research. Clinical Haematology|December 5, 2009
Standardisation of molecular monitoring for chronic myeloid leukaemiaNicholas C P Cross
Hematology. American Society of Hematology. Education Program|December 14, 2011
Genetic and epigenetic complexity in myeloproliferative neoplasmsNicholas C P Cross
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Update on CML-Like DisordersNicholas C P Cross
Acta Haematologica|June 21, 2008
Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disordersNicholas C P Cross, Andreas Reiter
International Journal of Hematology|September 13, 2014
Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiableKaterina Zoi, Nicholas C P Cross
Hematology/Oncology Clinics of North America|September 27, 2012
Acquired uniparental disomy in myeloproliferative neoplasmsJoannah Score, Nicholas C P Cross
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Genomics of Myeloproliferative NeoplasmsKaterina Zoi, Nicholas C P Cross
Clinical Science (London, England : 1979)|September 12, 2006
Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinasesAndrew Chase, Nicholas C P Cross
Pageof 23